Trial intelligence / Profile preview

Convalescent Plasma for Hospitalized COVID-19 Patients

NCT04344535Phase 2Terminated

Sponsor
Stony Brook University
Start
Apr 2020
Primary completion
Jan 2021
Modality
Biologic
Countries
1
01

Overview

A Phase 2 trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19), sponsored by Stony Brook University. Started Apr 2020; status: terminated.

02

Drugs

convalescent plasma (Heinrich-Heine University, Duesseldorf)
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04344535.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04344535.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call